Anti-infective protective properties of S100 calgranulins

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

Volumn 8, Issue 4, 2009, Pages 290-305

  Hsu, Kenneth ^a   Champaiboon, Chantrakorn ^b,c,d   Guenther, Brian D ^b,c   Sorenson, Brent S ^b,c   Khammanivong, Ali ^b,c   Ross, Karen F ^b,c   Geczy, Carolyn L ^a   Herzberg, Mark C ^b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VA MEDICAL CENTER   (United States)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Anti infection; Anti inflammation; Calgranulins; Induction; Keratinocytes; Macrophages; Structure

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BETA DEFENSIN 2; CALCIUM BINDING PROTEIN; CALGRANULIN A; CALGRANULIN B; CALGRANULIN C; CALVASCULIN; CASEIN KINASE I; CASEIN KINASE II; DNA DIRECTED RNA POLYMERASE; DNA TOPOISOMERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PSORIASIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RNA POLYMERASE II; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SEQUENCE; BACTERIAL IMMUNITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL PROTECTION; CYTOKINE PRODUCTION; CYTOSKELETON; ENZYME ACTIVATION; FIBROBLAST; FUNGUS IMMUNITY; HUMAN; INFLAMMATION; INNATE IMMUNITY; KERATINOCYTE; LEUKOCYTE MIGRATION; MACROPHAGE; MAST CELL; MICROBIAL IMMUNITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SPECIES COMPARISON;

EID: 73649098315     PISSN: 18715230     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152309789838975     Document Type: Review

References (224)

1. Foell, D.; Frosch, M.; Sorg, C.; Roth, J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin. Chim. Acta, 2004, 344(1-2), 37-51.
2. Salama, I.; Malone, P. S.; Mihaimeed, F.; Jones, J. L. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol., 2008, 34(4), 357-364.
3. Berntzen, H. B.; Fagerhol, M. K. L1, a major granulocyte protein: antigenic properties of its subunits. Scand. J. Clin. Lab. Invest., 1988, 48(7), 647-652.
4. Kerkhoff, C.; Klempt, M.; Sorg, C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim. Biophys. Acta, 1998, 1448(2), 200-211.
5. Honig, B.; Nicholls, A. Classical electrostatics in biology and chemistry. Science, 1995, 268 (5214), 1144-1149.
6. Sali, A.; Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol., 1993, 234(3), 779-815.
7. Champaiboon, C.; Sappington, K. J.; Guenther, B. D.; Ross, K. F.; Herzberg, M. C. Calprotectin S100A9 calcium-binding loops I and II are essential for keratinocyte resistance to bacterial invasion. J. Biol. Chem., 2009, 284(11), 7078-7090.
8. Korndorfer, I. P.; Brueckner, F.; Skerra, A. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. J. Mol. Biol., 2007, 370(5), 887-898.
9. Guex, N.; Peitsch, M. C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis, 1997, 18(15), 2714-2723.
10. Yan, W. X.; Armishaw, C.; Goyette, J.; Yang, Z.; Cai, H.; Alewood, P.; Geczy, C. L. Mast cell and monocyte recruitment by S100A12 and its hinge domain. J. Biol. Chem., 2008, 283(19), 13035-13043.
11. Moroz, O. V.; Blagova, E. V.; Wilkinson, A. J.; Wilson, K. S.; Bronstein, I. B. The crystal structures of human S100A12 in apo form and in complex with zinc: new insights into S100A12 oligomerisation. J. Mol. Biol., 2009, 391(3), 536-551.
12. Moroz, O. V.; Burkitt, W.; Wittkowski, H.; He, W.; Ianoul, A.; Novitskaya, V.; Xie, J.; Polyakova, O.; Lednev, I. K.; Shekhtman, A.; Derrick, P. J.; Bjoerk, P.; Foell, D.; Bronstein, I. B. Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function. BMC Biochem., 2009, 10, 11.
13. Yui, S.; Mikami, M.; Tsurumaki, K.; Yamazaki, M. Growthinhibitory and apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: regulation by metal ions. J. Leukoc. Biol., 1997, 61(1), 50-57.
14. Yui, S.; Nakatani, Y.; Hunter, M. J.; Chazin, W. J.; Yamazaki, M. Implication of extracellular zinc exclusion by recombinant human calprotectin (MRP8 and MRP14) from target cells in its apoptosisinducing activity. Mediators Inflamm., 2002, 11(3), 165-172.
15. Corbin, B. D.; Seeley, E. H.; Raab, A.; Feldmann, J.; Miller, M. R.; Torres, V. J.; Anderson, K. L.; Dattilo, B. M.; Dunman, P. M.; Gerads, R.; Caprioli, R. M.; Nacken, W.; Chazin, W. J.; Skaar, E. P. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science, 2008, 319(5865), 962-965.
16. Russell, D. G. Staphylococcus and the healing power of pus. Cell Host Microbe, 2008, 3(3), 115-116.
17. Sohnle, P. G.; Collins-Lech, C.; Wiessner, J. H. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J. Infect. Dis., 1991, 164(1), 137-142.
18. Moroz, O. V.; Antson, A. A.; Grist, S. J.; Maitland, N. J.; Dodson, G. G.; Wilson, K. S.; Lukanidin, E.; Bronstein, I. B. Structure of the human S100A12-copper complex: implications for hostparasite defence. Acta Crystallogr. D Biol. Crystallogr., 2003, 59(Pt 5), 859-867.
19. Moroz, O. V.; Dodson, G. G.; Wilson, K. S.; Lukanidin, E.; Bronstein, I. B. Multiple structural states of S100A12: a key to its functional diversity. Microsc. Res. Tech., 2003, 60(6), 581-592.
20. Tottey, S.; Waldron, K. J.; Firbank, S. J.; Reale, B.; Bessant, C.; Sato, K.; Cheek, T. R.; Gray, J.; Banfield, M. J.; Dennison, C.; Robinson, N. J. Protein-folding location can regulate manganesebinding versus copper- or zinc-binding. Nature, 2008, 455(7216), 1138-1142.
21. Leukert, N.; Vogl, T.; Strupat, K.; Reichelt, R.; Sorg, C.; Roth, J. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J. Mol. Biol., 2006, 359(4), 961-972.
22. Strupat, K.; Rogniaux, H.; Van Dorsselaer, A.; Roth, J.; Vogl, T., Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 are confirmed by electrospray ionization-mass analysis. J. Am. Soc. Mass Spectrom., 2000, 11(9), 780-788.
23. Vogl, T.; Roth, J.; Sorg, C.; Hillenkamp, F.; Strupat, K. Calciuminduced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption/ionization mass spectrometry. J. Am. Soc. Mass Spectrom., 1999, 10(11), 1124-1130.
24. Pietzsch, J.; Hoppmann, S. Human S100A12: a novel key player in inflammation? Amino Acids, 2009, 36(3), 381-389.
25. Moroz, O. V.; Antson, A. A.; Murshudov, G. N.; Maitland, N. J.; Dodson, G. G.; Wilson, K. S.; Skibshoj, I.; Lukanidin, E. M.; Bronstein, I. B. The three-dimensional structure of human S100A12. Acta Crystallogr. D Biol. Crystallogr., 2001, 57(Pt 1), 20-29.
26. Goyette, J.; Yan, W. X.; Yamen, E.; Chung, Y. M.; Lim, S. Y.; Hsu, K.; Rahimi, F.; Di Girolamo, N.; Song, C.; Jessup, W.; Kockx, M.; Bobryshev, Y. V.; Freedman, S. B.; Geczy, C. L. Pleiotropic roles of S100A12 in coronary atherosclerotic plaque formation and rupture. J. Immunol., 2009, 183(1), 593-603.
27. Rammes, A.; Roth, J.; Goebeler, M.; Klempt, M.; Hartmann, M.; Sorg, C., Myeloid-related protein (MRP) 8 and MRP14, calciumbinding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem., 1997, 272(14), 9496-9502.
28. Benedyk, M.; Sopalla, C.; Nacken, W.; Bode, G.; Melkonyan, H.; Banfi, B.; Kerkhoff, C. HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities. J. Invest. Dermatol., 2007, 127(8), 2001-2011.
29. Murao, S.; Collart, F. R.; Huberman, E., A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases. J. Biol. Chem., 1989, 264(14), 8356-8360.
30. Cheng, P.; Corzo, C. A.; Luetteke, N.; Yu, B.; Nagaraj, S.; Bui, M. M.; Ortiz, M.; Nacken, W.; Sorg, C.; Vogl, T.; Roth, J.; Gabrilovich, D. I. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med., 2008, 205(10), 2235-2249.
31. Huang, B.; Pan, P. Y.; Li, Q.; Sato, A. I.; Levy, D. E.; Bromberg, J.; Divino, C. M.; Chen, S. H. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res., 2006, 66(2), 1123-1131.
32. Rodriguez, P. C.; Ochoa, A. C. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol. Rev., 2008, 222, 180-191.
33. Haile, L. A.; von Wasielewski, R.; Gamrekelashvili, J.; Kruger, C.; Bachmann, O.; Westendorf, A. M.; Buer, J.; Liblau, R.; Manns, M. P.; Korangy, F.; Greten, T. F. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology, 2008, 135(3), 871-881, 881 e1-5.
34. Dugast, A. S.; Haudebourg, T.; Coulon, F.; Heslan, M.; Haspot, F.; Poirier, N.; Vuillefroy de Silly, R.; Usal, C.; Smit, H.; Martinet, B.; Thebault, P.; Renaudin, K.; Vanhove, B., Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J. Immunol., 2008, 180(12), 7898-7906.
35. Lim, S. Y.; Raftery, M.; Cai, H.; Hsu, K.; Yan, W. X.; Hseih, H. L.; Watts, R. N.; Richardson, D.; Thomas, S.; Perry, M.; Geczy, C. L. S-nitrosylated S100A8: novel anti-inflammatory properties. J. Immunol., 2008, 181(8), 5627-5636.
36. Klempt, M.; Melkonyan, H.; Nacken, W.; Wiesmann, D.; Holtkemper, U.; Sorg, C. The heterodimer of the Ca2+-binding proteins MRP8 and MRP14 binds to arachidonic acid. FEBS Lett., 1997, 408(1), 81-84.
37. Siegenthaler, G.; Roulin, K.; Chatellard-Gruaz, D.; Hotz, R.; Saurat, J. H.; Hellman, U.; Hagens, G. A heterocomplex formed by the calcium-binding proteins MRP8 (S100A8) and MRP14 (S100A9) binds unsaturated fatty acids with high affinity. J. Biol. Chem., 1997, 272(14), 9371-9377.
38. Kerkhoff, C.; Klempt, M.; Kaever, V.; Sorg, C. The two calciumbinding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils. J. Biol. Chem., 1999, 274(46), 32672-32679.
39. Nacken, W.; Roth, J.; Sorg, C.; Kerkhoff, C. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc. Res. Tech., 2003, 60(6), 569-580.
40. Kerkhoff, C.; Nacken, W.; Benedyk, M.; Dagher, M. C.; Sopalla, C.; Doussiere, J. The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. FASEB J., 2005, 19(3), 467-469.
41. Nisapakultorn, K.; Ross, K. F.; Herzberg, M. C., Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect. Immun., 2001, 69(7), 4242-4247.
42. Nisapakultorn, K.; Ross, K. F.; Herzberg, M. C. Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect. Immun., 2001, 69(6), 3692-3696.
43. Zaia, A. A.; Sappington, K. J.; Nisapakultorn, K.; Chazin, W. J.; Dietrich, E. A.; Ross, K. F.; Herzberg, M. C. Subversion of antimicrobial calprotectin (S100A8/S100A9 complex) in the cytoplasm of TR146 epithelial cells after invasion by Listeria monocytogenes. Mucosal Immunol., 2009, 2(1), 43-53.
44. Wu, N.; Davidson, J. M., Migration inhibitory factor-related protein (MRP)8 and MRP14 are differentially expressed in freeelectron laser and scalpel incisions. Wound Repair Regen., 2004, 12(3), 327-336.
45. Grimbaldeston, M. A.; Geczy, C. L.; Tedla, N.; Finlay-Jones, J. J.; Hart, P. H., S100A8 induction in keratinocytes by ultraviolet A irradiation is dependent on reactive oxygen intermediates. J. Invest. Dermatol., 2003, 121(5), 1168-1174.
46. Harrison, C. A.; Raftery, M. J.; Walsh, J.; Alewood, P.; Iismaa, S. E.; Thliveris, S.; Geczy, C. L. Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J. Biol. Chem., 1999, 274(13), 8561-8569.
47. Raftery, M. J.; Yang, Z.; Valenzuela, S. M.; Geczy, C. L., Novel intra- and inter-molecular sulfinamide bonds in S100A8 produced by hypochlorite oxidation. J. Biol. Chem., 2001, 276, (36), 33393-401.
48. Schnekenburger, J.; Schick, V.; Kruger, B.; Manitz, M. P.; Sorg, C.; Nacken, W.; Kerkhoff, C.; Kahlert, A.; Mayerle, J.; Domschke, W.; Lerch, M. M., The calcium binding protein S100A9 is essential for pancreatic leukocyte infiltration and induces disruption of cellcell contacts. J. Cell Physiol., 2008, 216, (2), 558-67.
49. Roth, J.; Burwinkel, F.; van den Bos, C.; Goebeler, M.; Vollmer, E.; Sorg, C., MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood, 1993, 82(6), 1875-1883.
50. van den Bos, C.; Roth, J.; Koch, H. G.; Hartmann, M.; Sorg, C. Phosphorylation of MRP14, an S100 protein expressed during monocytic differentiation, modulates Ca(2+)-dependent translocation from cytoplasm to membranes and cytoskeleton. J. Immunol., 1996, 156(3), 1247-1254.
51. Goebeler, M.; Roth, J.; van den Bos, C.; Ader, G.; Sorg, C. Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments. Biochem. J., 1995, 309(Pt 2), 419-424.
52. Burwinkel, F.; Roth, J.; Goebeler, M.; Bitter, U.; Wrocklage, V.; Vollmer, E.; Roessner, A.; Sorg, C.; Bocker, W. Ultrastructural localization of the S-100-like proteins MRP8 and MRP14 in monocytes is calcium-dependent. Histochemistry, 1994, 101(2), 113-120.
53. Vogl, T.; Ludwig, S.; Goebeler, M.; Strey, A.; Thorey, I. S.; Reichelt, R.; Foell, D.; Gerke, V.; Manitz, M. P.; Nacken, W.; Werner, S.; Sorg, C.; Roth, J. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood, 2004, 104(13), 4260-4268.
54. Leukert, N.; Sorg, C.; Roth, J. Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14). Biol. Chem., 2005, 386(5), 429-434.
55. Donato, R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol., 2001, 33(7), 637-668.
56. Foell, D.; Wittkowski, H.; Vogl, T.; Roth, J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol., 2007, 81(1), 28-37.
57. Voganatsi, A.; Panyutich, A.; Miyasaki, K. T.; Murthy, R. K. Mechanism of extracellular release of human neutrophil calprotectin complex. J. Leukoc. Biol., 2001, 70(1), 130-134.
58. Kido, J.; Hayashi, N.; Kataoka, M.; Nagata, T. Calprotectin expression in human monocytes: induction by porphyromonas gingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta. J. Periodontol., 2005, 76(3), 437-442.
59. Kido, J.; Kido, R.; Suryono; Kataoka, M.; Fagerhol, M. K.; Nagata, T. Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD-14-Toll-like receptor-nuclear factor kappaB pathway. J. Periodontal Res., 2003, 38(6), 557-563.
60. Buhimschi, C. S.; Buhimschi, I. A.; Abdel-Razeq, S.; Rosenberg, V. A.; Thung, S. F.; Zhao, G.; Wang, E.; Bhandari, V. Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr. Res., 2007, 61(3), 318-324.
61. Cuida, M.; Halse, A. K.; Johannessen, A. C.; Tynning, T.; Jonsson, R. Indicators of salivary gland inflammation in primary Sjogren's syndrome. Eur. J. Oral Sci., 1997, 105(3), 228-233.
62. Espinoza, J.; Chaiworapongsa, T.; Romero, R.; Edwin, S.; Rathnasabapathy, C.; Gomez, R.; Bujold, E.; Camacho, N.; Kim, Y. M.; Hassan, S.; Blackwell, S.; Whitty, J.; Berman, S.; Redman, M.; Yoon, B. H.; Sorokin, Y. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability- increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J. Matern. Fetal Neonatal Med., 2003, 13(1), 2-21.
63. Hammer, H. B.; Kvien, T. K.; Glennas, A.; Melby, K. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin. Exp. Rheumatol., 1995, 13(1), 59-64.
64. Kocher, M.; Kenny, P. A.; Farram, E.; Abdul Majid, K. B.; Finlay-Jones, J. J.; Geczy, C. L. Functional chemotactic factor CP-10 and MRP-14 are abundant in murine abscesses. Infect. Immun., 1996, 64(4), 1342-1350.
65. Frosch, M.; Strey, A.; Vogl, T.; Wulffraat, N. M.; Kuis, W.; Sunderkotter, C.; Harms, E.; Sorg, C.; Roth, J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthr. Rheum., 2000, 43 (3), 628-637.
66. Hetland, G.; Talgo, G. J.; Fagerhol, M. K. Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro. Mol. Pathol., 1998, 51(3), 143-148.
67. Hasegawa, T.; Kosaki, A.; Kimura, T.; Matsubara, H.; Mori, Y.; Okigaki, M.; Masaki, H.; Toyoda, N.; Inoue-Shibata, M.; Kimura, Y.; Nishikawa, M.; Iwasaka, T. The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages. Atherosclerosis, 2003, 171(2), 211-218.
68. Rahimi, F.; Hsu, K.; Endoh, Y.; Geczy, C. L. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8. FEBS J., 2005, 272(11), 2811-2827.
69. Edgeworth, J.; Gorman, M.; Bennett, R.; Freemont, P.; Hogg, N. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J. Biol. Chem., 1991, 266(12), 7706-7713.
70. Guignard, F.; Mauel, J.; Markert, M., Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem. J., 1995, 309( Pt 2), 395-401.
71. Galli, S. J.; Kalesnikoff, J.; Grimbaldeston, M. A.; Piliponsky, A. M.; Williams, C. M.; Tsai, M., Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol., 2005, 23, 749-786.
72. Trinchieri, G.; Sher, A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol., 2007, 7(3), 179-190.
73. Lackmann, M.; Cornish, C. J.; Simpson, R. J.; Moritz, R. L.; Geczy, C. L. Purification and structural analysis of a murine chemotactic cytokine (CP-10) with sequence homology to S100 proteins. J. Biol. Chem., 1992, 267(11), 7499-7504.
74. Lackmann, M.; Rajasekariah, P.; Iismaa, S. E.; Jones, G.; Cornish, C. J.; Hu, S.; Simpson, R. J.; Moritz, R. L.; Geczy, C. L. Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10. J. Immunol., 1993, 150(7), 2981-2991.
75. Devery, J. M.; King, N. J.; Geczy, C. L. Acute inflammatory activity of the S100 protein CP-10: activation of neutrophils in vivo and in vitro. J. Immunol., 1994, 152(4), 1888-1897.
76. Lau, W.; Devery, J. M.; Geczy, C. L. A chemotactic S100 peptide enhances scavenger receptor and Mac-1 expression and cholesteryl ester accumulation in murine peritoneal macrophages in vivo. J. Clin. Invest., 1995, 95(5), 1957-1965.
77. Miranda, L. P.; Tao, T.; Jones, A.; Chernushevich, I.; Standing, K. G.; Geczy, C. L.; Alewood, P. F. Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE). FEBS Lett., 2001, 488(1-2), 85-90.
78. Nisapakultorn, K.; Ross, K. F.; Herzberg, M. C., Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect. Immun., 2001, 69(7), 4242-4247.
79. Nisapakultorn, K.; Ross, K. F.; Herzberg, M. C. Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect. Immun., 2001, 69(6), 3692-3696.
80. Zaia, A. A.; Sappington, K. J.; Nisapakultorn, K.; Chazin, W. J.; Dietrich, E. A.; Ross, K. F.; Herzberg, M. C. Subversion of antimicrobial calprotectin (S100A8/S100A9 complex) in the cytoplasm of TR146 epithelial cells after invasion by Listeria monocytogenes. Mucosal Immunol., 2009, 2(1), 43-53.
81. Wu, N.; Davidson, J. M., Migration inhibitory factor-related protein (MRP)8 and MRP14 are differentially expressed in freeelectron laser and scalpel incisions. Wound Repair Regen., 2004, 12(3), 327-336.
82. Grimbaldeston, M. A.; Geczy, C. L.; Tedla, N.; Finlay-Jones, J. J.; Hart, P. H., S100A8 induction in keratinocytes by ultraviolet A irradiation is dependent on reactive oxygen intermediates. J. Invest. Dermatol., 2003, 121(5), 1168-1174.
83. Harrison, C. A.; Raftery, M. J.; Walsh, J.; Alewood, P.; Iismaa, S. E.; Thliveris, S.; Geczy, C. L. Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J. Biol. Chem., 1999, 274(13), 8561-8569.
84. Raftery, M. J.; Yang, Z.; Valenzuela, S. M.; Geczy, C. L., Novel intra- and inter-molecular sulfinamide bonds in S100A8 produced by hypochlorite oxidation. J. Biol. Chem., 2001, 276, (36), 33393-401.
85. Schnekenburger, J.; Schick, V.; Kruger, B.; Manitz, M. P.; Sorg, C.; Nacken, W.; Kerkhoff, C.; Kahlert, A.; Mayerle, J.; Domschke, W.; Lerch, M. M., The calcium binding protein S100A9 is essential for pancreatic leukocyte infiltration and induces disruption of cellcell contacts. J. Cell Physiol., 2008, 216, (2), 558-67.
86. Roth, J.; Burwinkel, F.; van den Bos, C.; Goebeler, M.; Vollmer, E.; Sorg, C., MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood, 1993, 82(6), 1875-1883.
87. van den Bos, C.; Roth, J.; Koch, H. G.; Hartmann, M.; Sorg, C. Phosphorylation of MRP14, an S100 protein expressed during monocytic differentiation, modulates Ca(2+)-dependent translocation from cytoplasm to membranes and cytoskeleton. J. Immunol., 1996, 156(3), 1247-1254.
88. Goebeler, M.; Roth, J.; van den Bos, C.; Ader, G.; Sorg, C. Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments. Biochem. J., 1995, 309(Pt 2), 419-424.
89. Burwinkel, F.; Roth, J.; Goebeler, M.; Bitter, U.; Wrocklage, V.; Vollmer, E.; Roessner, A.; Sorg, C.; Bocker, W. Ultrastructural localization of the S-100-like proteins MRP8 and MRP14 in monocytes is calcium-dependent. Histochemistry, 1994, 101(2), 113-120.
90. Vogl, T.; Ludwig, S.; Goebeler, M.; Strey, A.; Thorey, I. S.; Reichelt, R.; Foell, D.; Gerke, V.; Manitz, M. P.; Nacken, W.; Werner, S.; Sorg, C.; Roth, J. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood, 2004, 104(13), 4260-4268.
91. Leukert, N.; Sorg, C.; Roth, J. Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14). Biol. Chem., 2005, 386(5), 429-434.
92. Donato, R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol., 2001, 33(7), 637-668.
93. Foell, D.; Wittkowski, H.; Vogl, T.; Roth, J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol., 2007, 81(1), 28-37.
94. Voganatsi, A.; Panyutich, A.; Miyasaki, K. T.; Murthy, R. K. Mechanism of extracellular release of human neutrophil calprotectin complex. J. Leukoc. Biol., 2001, 70(1), 130-134.
95. Kido, J.; Hayashi, N.; Kataoka, M.; Nagata, T. Calprotectin expression in human monocytes: induction by porphyromonas gingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta. J. Periodontol., 2005, 76(3), 437-442.
96. Kido, J.; Kido, R.; Suryono; Kataoka, M.; Fagerhol, M. K.; Nagata, T. Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD-14-Toll-like receptor-nuclear factor kappaB pathway. J. Periodontal Res., 2003, 38(6), 557-563.
97. Buhimschi, C. S.; Buhimschi, I. A.; Abdel-Razeq, S.; Rosenberg, V. A.; Thung, S. F.; Zhao, G.; Wang, E.; Bhandari, V. Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr. Res., 2007, 61(3), 318-324.
98. Cuida, M.; Halse, A. K.; Johannessen, A. C.; Tynning, T.; Jonsson, R. Indicators of salivary gland inflammation in primary Sjogren's syndrome. Eur. J. Oral Sci., 1997, 105(3), 228-233.
99. Espinoza, J.; Chaiworapongsa, T.; Romero, R.; Edwin, S.; Rathnasabapathy, C.; Gomez, R.; Bujold, E.; Camacho, N.; Kim, Y. M.; Hassan, S.; Blackwell, S.; Whitty, J.; Berman, S.; Redman, M.; Yoon, B. H.; Sorokin, Y. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability- increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J. Matern. Fetal Neonatal Med., 2003, 13(1), 2-21.
100. Hammer, H. B.; Kvien, T. K.; Glennas, A.; Melby, K. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin. Exp. Rheumatol., 1995, 13(1), 59-64.
101. Kocher, M.; Kenny, P. A.; Farram, E.; Abdul Majid, K. B.; Finlay-Jones, J. J.; Geczy, C. L. Functional chemotactic factor CP-10 and MRP-14 are abundant in murine abscesses. Infect. Immun., 1996, 64(4), 1342-1350.
102. Frosch, M.; Strey, A.; Vogl, T.; Wulffraat, N. M.; Kuis, W.; Sunderkotter, C.; Harms, E.; Sorg, C.; Roth, J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthr. Rheum., 2000, 43 (3), 628-637.
103. Hetland, G.; Talgo, G. J.; Fagerhol, M. K. Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro. Mol. Pathol., 1998, 51(3), 143-148.
104. Hasegawa, T.; Kosaki, A.; Kimura, T.; Matsubara, H.; Mori, Y.; Okigaki, M.; Masaki, H.; Toyoda, N.; Inoue-Shibata, M.; Kimura, Y.; Nishikawa, M.; Iwasaka, T. The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages. Atherosclerosis, 2003, 171(2), 211-218.
105. Rahimi, F.; Hsu, K.; Endoh, Y.; Geczy, C. L. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8. FEBS J., 2005, 272(11), 2811-2827.
106. Edgeworth, J.; Gorman, M.; Bennett, R.; Freemont, P.; Hogg, N. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J. Biol. Chem., 1991, 266(12), 7706-7713.
107. Guignard, F.; Mauel, J.; Markert, M., Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem. J., 1995, 309( Pt 2), 395-401.
108. Galli, S. J.; Kalesnikoff, J.; Grimbaldeston, M. A.; Piliponsky, A. M.; Williams, C. M.; Tsai, M., Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol., 2005, 23, 749-786.
109. Trinchieri, G.; Sher, A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol., 2007, 7(3), 179-190.
110. Lackmann, M.; Cornish, C. J.; Simpson, R. J.; Moritz, R. L.; Geczy, C. L. Purification and structural analysis of a murine chemotactic cytokine (CP-10) with sequence homology to S100 proteins. J. Biol. Chem., 1992, 267(11), 7499-7504.
111. Lackmann, M.; Rajasekariah, P.; Iismaa, S. E.; Jones, G.; Cornish, C. J.; Hu, S.; Simpson, R. J.; Moritz, R. L.; Geczy, C. L. Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10. J. Immunol., 1993, 150(7), 2981-2991.
112. Devery, J. M.; King, N. J.; Geczy, C. L. Acute inflammatory activity of the S100 protein CP-10: activation of neutrophils in vivo and in vitro. J. Immunol., 1994, 152(4), 1888-1897.
113. Lau, W.; Devery, J. M.; Geczy, C. L. A chemotactic S100 peptide enhances scavenger receptor and Mac-1 expression and cholesteryl ester accumulation in murine peritoneal macrophages in vivo. J. Clin. Invest., 1995, 95(5), 1957-1965.
114. Miranda, L. P.; Tao, T.; Jones, A.; Chernushevich, I.; Standing, K. G.; Geczy, C. L.; Alewood, P. F. Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE). FEBS Lett., 2001, 488(1-2), 85-90.
115. Yang, Z.; Tao, T.; Raftery, M. J.; Youssef, P.; Di Girolamo, N.; Geczy, C. L. Proinflammatory properties of the human S100 protein S100A12. J. Leukoc. Biol., 2001, 69(6), 986-994.
116. Ravasi, T.; Hsu, K.; Goyette, J.; Schroder, K.; Yang, Z.; Rahimi, F.; Miranda, L. P.; Alewood, P. F.; Hume, D. A.; Geczy, C. Probing the S100 protein family through genomic and functional analysis. Genomics, 2004, 84(1), 10-22.
117. Ryckman, C.; Vandal, K.; Rouleau, P.; Talbot, M.; Tessier, P. A. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol., 2003, 170(6), 3233-3242.
118. Newton, R. A.; Hogg, N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J. Immunol., 1998, 160(3), 1427-1435.
119. Cornish, C. J.; Devery, J. M.; Poronnik, P.; Lackmann, M.; Cook, D. I.; Geczy, C. L. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J. Cell Physiol., 1996, 166(2), 427-437.
120. Hofmann, M. A.; Drury, S.; Fu, C.; Qu, W.; Taguchi, A.; Lu, Y.; Avila, C.; Kambham, N.; Bierhaus, A.; Nawroth, P.; Neurath, M. F.; Slattery, T.; Beach, D.; McClary, J.; Nagashima, M.; Morser, J.; Stern, D.; Schmidt, A. M., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell, 1999, 97(7), 889-901.
121. Chertov, O.; Yang, D.; Howard, O. M.; Oppenheim, J. J. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol. Rev., 2000, 177, 68-78.
122. Mahida, Y. R.; Cunliffe, R. N. Defensins and mucosal protection. Novartis Found Symp 2004, 263, 71-77; discussion 77-84, 211-8.
123. Grigat, J.; Soruri, A.; Forssmann, U.; Riggert, J.; Zwirner, J., Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 2007, 179(6), 3958-3965.
124. Meyer-Hoffert, U. Neutrophil-derived serine proteases modulate innate immune responses. Front Biosci., 2009, 14, 3409-3418.
125. Korkmaz, B.; Moreau, T.; Gauthier, F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie, 2008, 90(2), 227-42.
126. Raquil, M. A.; Anceriz, N.; Rouleau, P.; Tessier, P. A., Blockade of antimicrobial proteins S100A8 and S100A9 inhibits phagocyte migration to the alveoli in streptococcal pneumonia. J. Immunol., 2008, 180(5), 3366-3374.
127. Robinson, M. J.; Tessier, P.; Poulsom, R.; Hogg, N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J. Biol. Chem., 2002, 277(5), 3658-3665.
128. Anceriz, N.; Vandal, K.; Tessier, P. A. S100A9 mediates neutrophil adhesion to fibronectin through activation of beta2 integrins. Biochem. Biophys. Res. Commun., 2007, 354(1), 84-89.
129. Eue, I.; Pietz, B.; Storck, J.; Klempt, M.; Sorg, C. Transendothelial migration of 27E10+ human monocytes. Int. Immunol., 2000, 12(11), 1593-1604.
130. Manitz, M. P.; Horst, B.; Seeliger, S.; Strey, A.; Skryabin, B. V.; Gunzer, M.; Frings, W.; Schonlau, F.; Roth, J.; Sorg, C.; Nacken, W. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell Biol., 2003, 23(3), 1034-1043.
131. McNeill, E.; Conway, S. J.; Roderick, H. L.; Bootman, M. D.; Hogg, N. Defective chemoattractant-induced calcium signalling in S100A9 null neutrophils. Cell Calcium, 2007, 41(2), 107-121.
132. Tieu, D. D.; Kern, R. C.; Schleimer, R. P. Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J. Allergy Clin. Immunol., 2009, 124(1), 37-42.
133. Hobbs, J. A.; May, R.; Tanousis, K.; McNeill, E.; Mathies, M.; Gebhardt, C.; Henderson, R.; Robinson, M. J.; Hogg, N. Myeloid cell function in MRP-14 (S100A9) null mice. Mol. Cell Biol., 2003, 23(7), 2564-2576.
134. Vogl, T.; Tenbrock, K.; Ludwig, S.; Leukert, N.; Ehrhardt, C.; van Zoelen, M. A.; Nacken, W.; Foell, D.; van der Poll, T.; Sorg, C.; Roth, J. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med., 2007, 13(9), 1042-1049.
135. Nacken, W.; Mooren, F. C.; Manitz, M. P.; Bode, G.; Sorg, C.; Kerkhoff, C. S100A9 deficiency alters adenosine-5'-triphosphate induced calcium signalling but does not generally interfere with calcium and zinc homeostasis in murine neutrophils. Int. J. Biochem. Cell Biol., 2005, 37(6), 1241-1253.
136. Bischoff, S. C., Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat. Rev. Immunol., 2007, 7(2), 93-104.
137. Yang, Z.; Yan, W. X.; Cai, H.; Tedla, N.; Armishaw, C.; Di Girolamo, N.; Wang, H. W.; Hampartzoumian, T.; Simpson, J. L.; Gibson, P. G.; Hunt, J.; Hart, P.; Hughes, J. M.; Perry, M. A.; Alewood, P. F.; Geczy, C. L. S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. J. Allergy Clin. Immunol., 2007, 119(1), 106-114.
138. Echtenacher, B.; Mannel, D. N.; Hultner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature, 1996, 381(6577), 75-77.
139. Galli, S. J.; Grimbaldeston, M.; Tsai, M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol., 2008, 8(6), 478-486.
140. Kneilling, M.; Mailhammer, R.; Hultner, L.; Schonberger, T.; Fuchs, K.; Schaller, M.; Bukala, D.; Massberg, S.; Sander, C. A.; Braumuller, H.; Eichner, M.; Maier, K. L.; Hallmann, R.; Pichler, B. J.; Haubner, R.; Gawaz, M.; Pfeffer, K.; Biedermann, T.; Rocken, M. Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation. Blood, 2009, 114(8), 1696-1706.
141. Flynn, J. L.; Goldstein, M. M.; Chan, J.; Triebold, K. J.; Pfeffer, K.; Lowenstein, C. J.; Schreiber, R.; Mak, T. W.; Bloom, B. R. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity, 1995, 2(6), 561-572.
142. Pfeffer, K.; Matsuyama, T.; Kundig, T. M.; Wakeham, A.; Kishihara, K.; Shahinian, A.; Wiegmann, K.; Ohashi, P. S.; Kronke, M.; Mak, T. W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell, 1993, 73(3), 457-467.
143. Burns, A. R.; Bowden, R. A.; Abe, Y.; Walker, D. C.; Simon, S. I.; Entman, M. L.; Smith, C. W. P-selectin mediates neutrophil adhesion to endothelial cell borders. J. Leukoc. Biol., 1999, 65(3), 299-306.
144. Rattmann, Y. D.; Pereira, C. R.; Cury, Y.; Gremski, W.; Marques, M. C.; da Silva-Santos, J. E. Vascular permeability and vasodilation induced by the Loxosceles intermedia venom in rats: involvement of mast cell degranulation, histamine and 5-HT receptors. Toxicon, 2008, 51(3), 363-372.
145. Ley, K. The role of selectins in inflammation and disease. Trends Mol. Med., 2003, 9(6), 263-268.
146. Halliwell, B. Phagocyte-derived reactive species: salvation or suicide? Trends Biochem. Sci., 2006, 31(9), 509-515.
147. Lim, S. Y.; Raftery, M. J.; Goyette, J.; Hsu, K.; Geczy, C. L. Oxidative modifications of S100 proteins: functional regulation by redox. J. Leukoc. Biol., 2009, 86, 577-587.
148. Raftery, M. J.; Geczy, C. L. Electrospray low energy CID and MALDI PSD fragmentations of protonated sulfinamide crosslinked peptides. J. Am. Soc. Mass Spectrom., 2002, 13(6), 709-718.
149. McCormick, M. M.; Rahimi, F.; Bobryshev, Y. V.; Gaus, K.; Zreiqat, H.; Cai, H.; Lord, R. S.; Geczy, C. L. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J. Biol. Chem., 2005, 280(50), 41521-41529.
150. Hazell, L. J.; Arnold, L.; Flowers, D.; Waeg, G.; Malle, E.; Stocker, R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest., 1996, 97(6), 1535-1544.
151. Sroussi, H. Y.; Berline, J.; Dazin, P.; Green, P.; Palefsky, J. M. S100A8 triggers oxidation-sensitive repulsion of neutrophils. J. Dent. Res., 2006, 85(9), 829-833.
152. Sroussi, H. Y.; Berline, J.; Palefsky, J. M. Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro. J. Leukoc. Biol., 2007, 81(3), 818-824.
153. Sroussi, H. Y.; Kohler, G. A.; Agabian, N.; Villines, D.; Palefsky, J. M. Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation. FEMS Immunol. Med. Microbiol., 2009, 55(1), 55-61.
154. Jaffrey, S. R.; Erdjument-Bromage, H.; Ferris, C. D.; Tempst, P.; Snyder, S. H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol., 2001, 3(2), 193-197.
155. Hess, D. T.; Matsumoto, A.; Kim, S. O.; Marshall, H. E.; Stamler, J. S., Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol., 2005, 6(2), 150-166.
156. Perez-Mato, I.; Castro, C.; Ruiz, F. A.; Corrales, F. J.; Mato, J. M. Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol. J. Biol. Chem., 1999, 274(24), 17075-17079.
157. Yen, T.; Harrison, C. A.; Devery, J. M.; Leong, S.; Iismaa, S. E.; Yoshimura, T.; Geczy, C. L. Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli. Blood, 1997, 90(12), 4812-4821.
158. Xu, K.; Geczy, C. L. IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. J. Immunol., 2000, 164(9), 4916-4923.
159. Miyasaki, K. T.; Bodeau, A. L.; Murthy, A. R.; Lehrer, R. I. In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena. J. Dent. Res., 1993, 72(2), 517-523.
160. Miyasaki, K. T.; Bodeau, A. L.; Pohl, J.; Shafer, W. M. Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena. Antimicrob. Agents Chemother., 1993, 37(12), 2710-2715.
161. Murthy, A. R.; Lehrer, R. I.; Harwig, S. S.; Miyasaki, K. T. In vitro candidastatic properties of the human neutrophil calprotectin complex. J. Immunol., 1993, 151(11), 6291-6301.
162. Lusitani, D.; Malawista, S. E.; Montgomery, R. R. Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi. Infect. Immun., 2003, 71(8), 4711-4716.
163. Gottsch, J. D.; Li, Q.; Ashraf, F.; O'Brien, T. P.; Stark, W. J.; Liu, S. H. Cytokine-induced calgranulin C expression in keratocytes. Clin. Immunol., 1999, 91(1), 34-40.
164. Cole, A. M.; Kim, Y. H.; Tahk, S.; Hong, T.; Weis, P.; Waring, A. J.; Ganz, T., Calcitermin, a novel antimicrobial peptide isolated from human airway secretions. FEBS Lett., 2001, 504(1-2), 5-10.
165. Sohnle, P. G.; Hunter, M. J.; Hahn, B.; Chazin, W. J. Zincreversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J. Infect. Dis., 2000, 182(4), 1272-1275.
166. Kido, J.; Nakamura, T.; Kido, R.; Ohishi, K.; Yamauchi, N.; Kataoka, M.; Nagata, T., Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease. J. Clin. Periodontol., 1999, 26(10), 653-657.
167. Eversole, L. R.; Miyasaki, K. T.; Christensen, R. E., Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases. J. Oral Pathol. Med., 1993, 22(7), 303-307.
168. Leach, S. T.; Mitchell, H. M.; Geczy, C. L.; Sherman, P. M.; Day, A. S., S100 calgranulin proteins S100A8, S100A9 and S100A12 are expressed in the inflamed gastric mucosa of Helicobacter pylori-infected children. Can. J. Gastroenterol., 2008, 22(5), 461-4.
169. Srikrishna, G.; Panneerselvam, K.; Westphal, V.; Abraham, V.; Varki, A.; Freeze, H. H., Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J. Immunol., 2001, 166(7), 4678-4688.
170. Kerkhoff, C.; Sorg, C.; Tandon, N. N.; Nacken, W. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry, 2001, 40(1), 241-248.
171. Pouliot, P.; Plante, I.; Raquil, M. A.; Tessier, P. A.; Olivier, M. Myeloid-related proteins rapidly modulate macrophage nitric oxide production during innate immune response. J. Immunol., 2008, 181(5), 3595-3601.
172. Arumugam, T.; Simeone, D. M.; Van Golen, K.; Logsdon, C. D. S100P promotes pancreatic cancer growth, survival, and invasion. Clin. Cancer Res., 2005, 11(15), 5356-5364.
173. Wolf, R.; Howard, O. M.; Dong, H. F.; Voscopoulos, C.; Boeshans, K.; Winston, J.; Divi, R.; Gunsior, M.; Goldsmith, P.; Ahvazi, B.; Chavakis, T.; Oppenheim, J. J.; Yuspa, S. H., Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J. Immunol., 2008, 181(2), 1499-1506.
174. Hsieh, H. L.; Schafer, B. W.; Weigle, B.; Heizmann, C. W. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem. Biophys. Res. Commun., 2004, 316(3), 949-959.
175. Ghavami, S.; Rashedi, I.; Dattilo, B. M.; Eshraghi, M.; Chazin, W. J.; Hashemi, M.; Wesselborg, S.; Kerkhoff, C.; Los, M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukoc. Biol., 2008, 83(6), 1484-1492.
176. Boyd, J. H.; Kan, B.; Roberts, H.; Wang, Y.; Walley, K. R. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ. Res., 2008, 102(10), 1239-1246.
177. Hermani, A.; De Servi, B.; Medunjanin, S.; Tessier, P. A.; Mayer, D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res., 2006, 312(2), 184-197.
178. Turovskaya, O.; Foell, D.; Sinha, P.; Vogl, T.; Newlin, R.; Nayak, J.; Nguyen, M.; Olsson, A.; Nawroth, P. P.; Bierhaus, A.; Varki, N.; Kronenberg, M.; Freeze, H. H.; Srikrishna, G. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitisassociated carcinogenesis. Carcinogenesis, 2008, 29(10), 2035-2043.
179. Ehlermann, P.; Eggers, K.; Bierhaus, A.; Most, P.; Weichenhan, D.; Greten, J.; Nawroth, P. P.; Katus, H. A.; Remppis, A. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovasc. Diabetol., 2006, 5, 6.
180. Ehrchen, J. M.; Sunderkotter, C.; Foell, D.; Vogl, T.; Roth, J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol., 2009, 86, 557-566.
181. Koike, T.; Harada, N.; Yoshida, T.; Morikawa, M., Regulation of myeloid-specific calcium binding protein synthesis by cytosolic protein kinase C. J. Biochem., 1992, 112(5), 624-630.
182. Sellmayer, A.; Krane, S. M.; Ouellette, A. J.; Bonventre, J. V. 1 alpha,25-(OH)2 vitamin D3 enhances expression of the genes encoding Ca(2+)-binding proteins MRP-8 and MRP-14. Am. J. Physiol., 1992, 262(1 Pt 1), C235-42.
183. Kerkhoff, C.; Hofmann, H. A.; Vormoor, J.; Melkonyan, H.; Roth, J.; Sorg, C.; Klempt, M. Binding of two nuclear complexes to a novel regulatory element within the human S100A9 promoter drives the S100A9 gene expression. J. Biol. Chem., 2002, 277(44), 41879-41887.
184. Hessian, P. A.; Edgeworth, J.; Hogg, N., MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J. Leukoc. Biol., 1993, 53(2), 197-204.
185. Hsu, K.; Passey, R. J.; Endoh, Y.; Rahimi, F.; Youssef, P.; Yen, T.; Geczy, C. L. Regulation of S100A8 by glucocorticoids. J. Immunol., 2005, 174(4), 2318-2326.
186. Lagasse, E.; Clerc, R. G. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol. Cell Biol., 1988, 8(6), 2402-2410.
187. Zwadlo, G.; Bruggen, J.; Gerhards, G.; Schlegel, R.; Sorg, C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin. Exp. Immunol., 1988, 72(3), 510-515.
188. Kerkhoff, C.; Vogl, T.; Nacken, W.; Sopalla, C.; Sorg, C. Zinc binding reverses the calcium-induced arachidonic acid-binding capacity of the S100A8/A9 protein complex. FEBS Lett., 1999, 460(1), 134-138.
189. Robinson, M. J.; Hogg, N. A comparison of human S100A12 with MRP-14 (S100A9). Biochem. Biophys. Res. Commun., 2000, 275(3), 865-870.
190. Suryono; Kido, J.; Hayashi, N.; Kataoka, M.; Shinohara, Y.; Nagata, T. Norepinephrine stimulates calprotectin expression in human monocytic cells. J. Periodontal. Res., 2006, 41(3), 159-164.
191. Vonk, A. G.; Netea, M. G.; van Krieken, J. H.; Iwakura, Y.; van der Meer, J. W.; Kullberg, B. J. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. J. Infect. Dis., 2006, 193(10), 1419-1426.
192. Mizutani, H.; Black, R.; Kupper, T. S. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J. Clin. Invest., 1991, 87(3), 1066-1071.
193. Ross, K. F.; Herzberg, M. C. Calprotectin expression by gingival epithelial cells. Infect. Immun., 2001, 69(5), 3248-3254.
194. Wolk, K.; Witte, E.; Wallace, E.; Docke, W. D.; Kunz, S.; Asadullah, K.; Volk, H. D.; Sterry, W.; Sabat, R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol., 2006, 36(5), 1309-1323.
195. Wolk, K.; Kunz, S.; Witte, E.; Friedrich, M.; Asadullah, K.; Sabat, R. IL-22 increases the innate immunity of tissues. Immunity, 2004, 21(2), 241-254.
196. Hayashi, N.; Kido, J.; Kido, R.; Wada, C.; Kataoka, M.; Shinohara, Y.; Nagata, T. Regulation of calprotectin expression by interleukin-1alpha and transforming growth factor-beta in human gingival keratinocytes. J. Periodontal Res., 2007, 42(1), 1-7.
197. Bando, M.; Hiroshima, Y.; Kataoka, M.; Shinohara, Y.; Herzberg, M. C.; Ross, K. F.; Nagata, T.; Kido, J. Interleukin-1alpha regulates antimicrobial peptide expression in human keratinocytes. Immunol. Cell Biol., 2007, 85(7), 532-537.
198. Boniface, K.; Bernard, F. X.; Garcia, M.; Gurney, A. L.; Lecron, J. C.; Morel, F., IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol., 2005, 174(6), 3695-3702.
199. Henke, M. O.; Renner, A.; Rubin, B. K.; Gyves, J. I.; Lorenz, E.; Koo, J. S., Up-regulation of S100A8 and S100A9 protein in bronchial epithelial cells by lipopolysaccharide. Exp. Lung Res., 2006, 32(8), 331-347.
200. Kelly, S. E.; Jones, D. B.; Fleming, S. Calgranulin expression in inflammatory dermatoses. J. Pathol., 1989, 159(1), 17-21.
201. Nickoloff, B. J.; Xin, H.; Nestle, F. O.; Qin, J. Z., The cytokine and chemokine network in psoriasis. Clin. Dermatol., 2007, 25(6), 568-573.
202. Brandtzaeg, P.; Dale, I.; Fagerhol, M. K. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am. J. Clin. Pathol., 1987, 87(6), 700-707.
203. Madsen, P.; Rasmussen, H. H.; Leffers, H.; Honore, B.; Celis, J. E. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J. Invest. Dermatol., 1992, 99(3), 299-305.
204. Thorey, I. S.; Roth, J.; Regenbogen, J.; Halle, J. P.; Bittner, M.; Vogl, T.; Kaesler, S.; Bugnon, P.; Reitmaier, B.; Durka, S.; Graf, A.; Wockner, M.; Rieger, N.; Konstantinow, A.; Wolf, E.; Goppelt, A.; Werner, S. The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J. Biol. Chem., 2001, 276(38), 35818-35825.
205. Gabrielsen, T. O.; Dale, I.; Brandtzaeg, P.; Hoel, P. S.; Fagerhol, M. K.; Larsen, T. E.; Thune, P. O. Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases. J. Am. Acad. Dermatol., 1986, 15(2 Pt 1), 173-179.
206. Mirmohammadsadegh, A.; Tschakarjan, E.; Ljoljic, A.; Bohner, K.; Michel, G.; Ruzicka, T.; Goos, M.; Hengge, U. R. Calgranulin C is overexpressed in lesional psoriasis. J. Invest. Dermatol., 2000, 114(6), 1207-1208.
207. Klempt, M.; Melkonyan, H.; Hofmann, H. A.; Eue, I.; Sorg, C. The transcription factors c-myb and C/EBP alpha regulate the monocytic/ myeloic gene MRP14. Immunobiology, 1998, 199(1), 148-151.
208. DiSepio, D.; Malhotra, M.; Chandraratna, R. A.; Nagpal, S., Retinoic acid receptor-nuclear factor-interleukin 6 antagonism. A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker. J. Biol. Chem., 1997, 272(41), 25555-25559.
209. Goerdt, S.; Orfanos, C. E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity, 1999, 10(2), 137-142.
210. Mantovani, A.; Sica, A.; Locati, M. Macrophage polarization comes of age. Immunity, 2005, 23(4), 344-346.
211. Martinez, F. O.; Sica, A.; Mantovani, A.; Locati, M., Macrophage activation and polarization. Front Biosci., 2008, 13, 453-61.
212. Mills, C. D.; Kincaid, K.; Alt, J. M.; Heilman, M. J.; Hill, A. M., M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000, 164, (12), 6166-73.
213. Mosser, D. M.; Edwards, J. P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol., 2008, 8(12), 958-969.
214. Xu, K.; Yen, T.; Geczy, C. L. IL-10 up-regulates macrophage expression of the S100 protein S100A8. J. Immunol., 2001, 166(10), 6358-6366.
215. Hu, S. P.; Harrison, C.; Xu, K.; Cornish, C. J.; Geczy, C. L. Induction of the chemotactic S100 protein, CP-10, in monocyte/ macrophages by lipopolysaccharide. Blood, 1996, 87(9), 3919-3928.
216. Endoh, Y.; Chung, Y. M.; Clark, I. A.; Geczy, C. L.; Hsu, K., IL-10-dependent S100A8 gene induction in monocytes/macrophages by double-stranded RNA. J. Immunol., 2009, 182(4), 2258-2268.
217. Bozinovski, S.; Cross, M.; Vlahos, R.; Jones, J. E.; Hsuu, K.; Tessier, P. A.; Reynolds, E. C.; Hume, D. A.; Hamilton, J. A.; Geczy, C. L.; Anderson, G. P. S100A8 chemotactic protein is abundantly increased, but only a minor contributor to LPS-induced, steroid resistant neutrophilic lung inflammation in vivo. J. Proteome Res., 2005, 4(1), 136-145.
218. Kumar, A.; Steinkasserer, A.; Berchtold, S. Interleukin-10 influences the expression of MRP8 and MRP14 in human dendritic cells. Int. Arch. Allergy Immunol., 2003, 132(1), 40-47.
219. Bai, B.; Yamamoto, K.; Sato, H.; Sugiura, H.; Tanaka, T., Complex regulation of S100A8 by IL-17, dexamethasone, IL-4 and IL-13 in HaCat cells (human keratinocyte cell line). J. Dermatol. Sci., 2007, 47(3), 259-262.
220. Gebhardt, C.; Breitenbach, U.; Tuckermann, J. P.; Dittrich, B. T.; Richter, K. H.; Angel, P. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene, 2002, 21(27), 4266-4276.
221. Couper, K. N.; Blount, D. G.; Riley, E. M. IL-10: the master regulator of immunity to infection. J. Immunol., 2008, 180(9), 5771-5777.
222. Wilckens, T. Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction. Trends Pharmacol. Sci., 1995, 16(6), 193-197.
223. Odink, K.; Cerletti, N.; Bruggen, J.; Clerc, R. G.; Tarcsay, L.; Zwadlo, G.; Gerhards, G.; Schlegel, R.; Sorg, C. Two calciumbinding proteins in infiltrate macrophages of rheumatoid arthritis. Nature, 1987, 330(6143), 80-82.
224. Pascual, G.; Glass, C. K. Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol. Metab., 2006, 17(8), 321-327.